Markets

Fate Therapeutics (FATE) Surges: Stock Moves 6.8% Higher

Fate Therapeutics, Inc. FATE was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $16.32 to $19.55 in the past one-month time frame.

The company has seen five negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Fate Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Fate Therapeutics, Inc. Price

Fate Therapeutics, Inc. Price

Fate Therapeutics, Inc. price | Fate Therapeutics, Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider Acorda Therapeutics, Inc. ACOR, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is FATE going up? Or down? Predict to see what others think:Up or Down

Will you retire a millionaire?

One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”

Click to get it free >>


Click to get this free report

Acorda Therapeutics, Inc. (ACOR): Free Stock Analysis Report

Fate Therapeutics, Inc. (FATE): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More